News

OtoNexus Wins WomenCorporateDirectors Launch Zone Competition

June 19th, 2019

We are delighted to announce being voted winner of the WomenCorporateDirectors Foundation (WCD) “Launch Zone” competition for women-led companies, held in Santa Clara, CA. OtoNexus presented before a panel of judges who represent angel investors, private equity and investment banking. The audience was comprised of more than 200 women corporate board members from 23 countries–attendees of the 2019 WCD Global Institute, WCD’s largest membership gathering of the year. Both attendees and judges voted, with OtoNexus winning both the audience vote and the judges’ vote (Link).

OtoNexus Awarded Another Federal Grant - National Science Foundation (NSF) Phase II SBIR Grant

March 19th, 2019

OtoNexus was honored to be awarded a National Science Foundation (NSF) SBIR Phase II Grant, covering key elements of our product development. This grant was a follow-on grant to our successful NSF Phase I grant. Companies funded by NSF SBIR Phase II grants have demonstrated transformational technology with enormous potential societal and market impact, presenting a unique and significant opportunity to change the status quo.

OtoNexus Medical Technologies and Fraunhofer IPMS Partnership

November 12th, 2018

OtoNexus is pleased to announce our partnership with Fraunhofer IPMS (Dresden, Germany) to continue the development of our ultrasound transducers.

OtoNexus Debuts at MEDICA

November 11th, 2018

OtoNexus exhibited at MEDICA, the largest medical industry trade show in the world, and the premier place for companies like ours to introduce innovative technologies to the medical world. MEDICA is held each year in Düsseldorf, Germany and is attended by 150,000+ attendees from around the world, not counting exhibitors. This was an important opportunity to present our disruptive technology to the medical world and allowed OtoNexus to establish new relationships for local and international partnerships.

MedTech Strategist Features OtoNexus in Startups to Watch

October 31st, 2018

MedTech Strategist, an important industry publication in the medical device field, publishes its Startups to Watch series to spotlight up-and-comers in the medical device industry. Following a lengthy interview, the MedTech Strategist described our vision on diagnosis for otitis media and the current market need for our device. OtoNexus is described as an easy-to- use handheld device that can identify the presence and type of infection in the middle ear in seconds, matching clinician’s current steps, workflow, and standard of care (MedTech Link).

CEO Cameron presents at the Angel Investing in Women-Led Companies event hosted by Golden Seeds and the Anita Borg Institute

October 30th, 2018

Caitlin Cameron, Chair and CEO, was delighted to be a panelist at the Angel Investing in Women-Led Companies event hosted by Golden Seeds and the Anita Borg Institute in Palo Alto, CA. This event was a great opportunity for Caitlin to share her vision and experience with entrepreneurs and the investors community and talk about how to build successful companies.

Caitlin Cameron chosen as a finalist for 2018 EY’s Pacific Northwest Entrepreneur of the Year

May 8th, 2018

EY’s annual Entrepreneur of the Year program recognizes the endeavors of top entrepreneur leaders who create products or services that keep our worldwide economy moving forward. Since its inception, Entrepreneur of The Year has grown dramatically and now includes programs in more than 60 countries and 145 cities worldwide. Caitlin was a finalist for this prestigious award, recognizing her leadership and success leading OtoNexus Medical Technologies. (GeekWire Link)

Life Science Washington (LSW) Spotlight: A conversation with LSW’s new Board Chair, Caitlin Cameron

April 12th, 2018

Life Science Washington recently sat down with our CEO, Caitlin Cameron, to get her perspective on Washington’s life science ecosystem, LSW’s role in it, and her vision for the industry’s future. (LSW Link)

Caitlin Cameron Selected as Board Chair of Life Science Washington (LSW)

December 27th, 2017

Life Science Washington, the trade association for Washington state’s life sciences and biotechnology industries and one of the largest Life Science trade associations in the US, appointed OtoNexus Medical Technologies Chair & CEO Caitlin Cameron as the Chair of its Board of Directors for 2018 and 2019.  It is an honor to have our CEO chosen to lead and represent the life science community in Washington (GeekWire Link).

Mayo Clinic Pediatric Days

October 17th, 2017

OtoNexus is honored to have been invited by Mayo Clinic to participate in The Mayo Clinic Pediatric Days. This prestigious event was attended by pediatricians and pediatric nurse practitioners. It was an opportunity to introduce our clinical solution to attendees and get invaluable pre-launch feedback. Mayo Clinic has a very strong focus on antimicrobial stewardship and provided courses on helping clinicians manage parental pressure to prescribe antibiotics. The response to our technology was tremendous and strongly reinforced the need for our simple and elegant diagnostic tool.

Entrepreneur Boot Camp

November 5th, 2017

Our CEO, Caitlin Cameron, was a key speaker at the Entrepreneur Boot Camp hosted by Keiretsu Forum and Microsoft. Caitlin provided training for entrepreneurs and investors on “Building to Exit”.  The training focused on how to build a company for a successful exit and highlighted the need to build the exit plan into the company plan and actions from “Day One”. This training has since been requested and repeated many times.

National Science Foundation (NSF) Phase I SBIR Grant

July 17th, 2017

OtoNexus was also awarded a National Science Foundation (NSF) SBIR Phase I Grant for $225,000. NSF is known to place greater emphasize on technology innovation and the commercial potential of the company.

National Institute of Health (NIH) Fast-Track SBIR Grant

June 10th, 2017

OtoNexus was honored to have been awarded a Fast-Track SBIR Grant from the National Institutes of Health (NIH) for $1.15 Million. Fast-Track grants combine Phase I and Phase II, and are much more competitive than standard grants. This is a wonderful endorsement of our technology by NIH.

OtoNexus awarded AdvaMed Scholarship

October 21st, 2016

AdvaMed, the MedTech Conference, the leading event for medical technology professionals in North America, announced today that 48 early-stage companies have been selected to participate in the Innovation Showcase, an exhibition presenting the latest medtech innovations, offered under scholarships provided by sponsor organizations. OtoNexus was delighted to been selected for this award.

OtoNexus Selected by Future in Review (FiRe) as a FiReStarter Company

July 9th, 2016

OtoNexus is honored to have been selected by Future in Review (FiRe) as a FiReStarter Company!  As a result, the company will be featured at the 14th Annual Future in Review Conference in Park City, Utah, September 27-30.  This conference is described by The Economist magazine as “The best technology conference in the world.”

Future in Review (FiRe) is focused on predicting the future, identifying likely outcomes and what technology will have the greatest impact in determining what lies ahead - and they have been amazingly accurate in their predictions.    Their focus related to young companies like ours is to identify the few that they believe have the greatest potential for bringing about transformative change.  They select only twelve companies each year, from nominations from across the globe.

Being designated as a FiReStarter Company is a rare and highly coveted honor that puts OtoNexus in an elite class – Tesla was an early FiRe honoree.

Joining us for this event will be the top leaders of technology, finance and telecommunications, in addition to top levels of global press. Click here for more information about the conference: www.futureinreview.com. Click here for the press release.

OtoNexus Wins Angel Capital Association Innovation Showcase

May 18th, 2016

OtoNexus was nominated for and subsequently honored with being selected to be a part of the Angel Capital Association’s Innovation Showcase, at this year’s ACA Annual Summit in Philadelphia.  Fifty companies were selected to be a part of the Showcase from nominations from around the country.  This was a juried event; just being selected to be in the Showcase was a big win.  

At the event, all Angels voted for the Innovation Showcase companies they felt were the best. At the final Keynote, the winners were announced.  OtoNexus was selected as the National Winner of the Innovation Showcase!

Winner of Seattle's InnovateHER Competition

April 5th, 2016

OtoNexus Medical Technologies is delighted to have been selected as the winner of Seattle’s InnovateHER ShowcaseInnovateHER: Innovating for Women Business Showcase is a Small Business Association (SBA) initiative in support of women-owned and women-led businesses.  InnovateHER in Seattle was sponsored by Microsoft Ventures.  More than 30 companies participated; eight made it to the final round, and OtoNexus was selected as the winner out of a terrific field of women-owned and women-led businesses.

OtoNexus Profiled in Seattle Business Magazine.

December 28th, 2015

Awards & Industry Recognition


Community Involvement

Support and Funding